Inhalation Sciences AB (publ) releases Q3 Report 2022
(Stockholm, Sweden, 22 November 2022) Inhalation Sciences AB announces that its interim report for the third quarter 2022 is now available on the company’s website. To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/Summary of interim Q3 report Commercial: through carefully qualified sales work, we are seeing a steady increase in enquiries and continue to work on converting these into assignments as quickly as possible. In the third quarter, order intake increased by 370% compared to the same period last year. Revenue also increased by 56%